Abstract
Matrix metalloproteinases (MMPs) are zinc-endopeptidases with multifactorial actions in central nervous system (CNS) physiology and pathology1. Accumulating data suggest that MMPs have a deleterious role in stroke. By degrading neurovascular matrix, MMPs promote injury of the blood-brain barrier, edema and hemorrhage2,3,4. By disrupting cell-matrix signaling and homeostasis, MMPs trigger brain cell death5,6. Hence, there is a movement toward the development of MMP inhibitors for acute stroke therapy. But MMPs may have a different role during delayed phases after stroke. Because MMPs modulate brain matrix, they may mediate beneficial plasticity and remodeling during stroke recovery. Here, we show that MMPs participate in delayed cortical responses after focal cerebral ischemia in rats. MMP-9 is upregulated in peri-infarct cortex at 7–14 days after stroke and is colocalized with markers of neurovascular remodeling. Treatment with MMP inhibitors at 7 days after stroke suppresses neurovascular remodeling, increases ischemic brain injury and impairs functional recovery at 14 days. MMP processing of bioavailable VEGF may be involved because inhibition of MMPs reduces endogenous VEGF signals, whereas additional treatment with exogenous VEGF prevents MMP inhibitor–induced worsening of infarction. These data suggest that, contrary to MMP inhibitor therapies for acute stroke, strategies that modulate MMPs may be needed for promoting stroke recovery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yong, V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931–944 (2005).
Asahi, M. et al. Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724–7732 (2001).
Wang, X. et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9, 1313–1317 (2003).
Lo, E.H., Dalkara, T. & Moskowitz, M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399–415 (2003).
Lee, S.R. & Lo, E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24, 720–727 (2004).
Gu, Z. et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401–6408 (2005).
Gasche, Y. et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19, 1020–1028 (1999).
Heo, J.H. et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624–633 (1999).
Mun-Bryce, S. & Rosenberg, G.A. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163–1172 (1998).
Dijkhuizen, R.M. et al. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J. Neurosci. 23, 510–517 (2003).
Kim, Y.R. et al. Measurements of BOLD/CBV ratio show altered fMRI hemodynamics during stroke recovery in rats. J. Cereb. Blood Flow Metab. 25, 820–829 (2005).
Reeves, T.M., Prins, M.L., Zhu, J., Povlishock, J.T. & Phillips, L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23, 10182–10189 (2003).
Wallace, C.S. et al. Correspondence between sites of NGFI-A induction and sites of morphological plasticity following exposure to environmental complexity. Brain Res. Mol. Brain Res. 32, 211–220 (1995).
Jones, M.W. et al. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci. 4, 289–296 (2001).
Irving, E.A. et al. Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J. Cereb. Blood Flow Metab. 25, 98–107 (2005).
Omura, K. et al. Recovery of blood-nerve barrier in crush nerve injury – a quantitative analysis utlizing immunohistochemistry. Brain Res. 1001, 13–21 (2004).
Larsen, P.H., Wells, J.E., Stallcup, W.B., Opdenakker, G. & Yong, V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23, 11127–11135 (2003).
Pang, P.T. et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487–491 (2004).
Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737–744 (2000).
Zhang, Z.G. et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829–838 (2000).
Cramer, S.C. & Chopp, M. Recovery recapitulates ontogeny. Trends Neurosci. 23, 265–271 (2000).
Chmielnicki, E. & Goldman, S.A. Induced neurogenesis by endogenous progenitor cells in the adult mammalian brain. Prog. Brain Res. 138, 451–464 (2002).
Kaczmarek, L., Lapinska-Dzwonek, J. & Szymczak, S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 21, 6643–6648 (2002).
Pepper, M.S. Role of the matrix metalloproteinase and plasmminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104–1117 (2001).
Manoonkitiwongsa, P.S., Jackson-Friedman, C., Mcmillan, P.J., Schultz, R.L. & Lyden, P.D. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J. Cereb. Blood Flow Metab. 21, 1223–1231 (2001).
Silva, E.A. & Mooney, D.J. Synthetic extracellular matrices for tissue engineering and regeneration. Curr. Top. Dev. Biol. 64, 181–205 (2004).
Montaner, J. et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32, 1759–1766 (2001).
Montaner, J. et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107, 598–603 (2003).
Lee, S.R., Tsuji, K., Lee, S.R. & Lo, E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J. Neurosci. 24, 671–678 (2004).
Taguchi, A. et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330–338 (2004).
Acknowledgements
This work was supported in part by US National Institutes of Health grants R01-NS37074, R01-NS40529, R01-NS48422, R01-EB02066, P50-NS10828 (to E.H.L.), R01-EBO2066 (to B.R.R.), a Howard Hughes Medical Research Training Fellowship (to S.W.), and a Bugher award from the American Heart Association (to E.H.L.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
MMP-9 expression at 24 h after stroke. (PDF 194 kb)
Supplementary Fig. 2
Neuroprotection in MMP-9 knockout neuronal cultures. (PDF 29 kb)
Supplementary Fig. 3
Increased cortical infarction after delayed MMP inhibition. (PDF 107 kb)
Supplementary Fig. 4
RECA-1 staining of vascular remodeling in peri-infarct cortex. (PDF 120 kb)
Rights and permissions
About this article
Cite this article
Zhao, BQ., Wang, S., Kim, HY. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12, 441–445 (2006). https://doi.org/10.1038/nm1387
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1387
This article is cited by
-
Brain Maturation as a Fundamental Factor in Immune-Neurovascular Interactions in Stroke
Translational Stroke Research (2024)
-
Elevated NT-proBNP predicts unfavorable outcomes in patients with acute ischemic stroke after thrombolytic therapy
BMC Neurology (2023)
-
An overview of hyperbaric oxygen preconditioning against ischemic stroke
Metabolic Brain Disease (2023)
-
The neurovascular unit and systemic biology in stroke — implications for translation and treatment
Nature Reviews Neurology (2022)
-
Delayed rFGF21 Administration Improves Cerebrovascular Remodeling and White Matter Repair After Focal Stroke in Diabetic Mice
Translational Stroke Research (2022)